Released FDA docs reveal details of agency’s (failed) attempt to retract paper

Earlier this year, a raging controversy regarding a new drug spilled into the pages of a leading medical journal: the head of the U.S. Food and Drug Administration and another official publicly called for the retraction or correction of a peer-reviewed article about the drug. They didn’t get their wish. Now, documents released by the […]

The post Released FDA docs reveal details of agency’s (failed) attempt to retract paper appeared first on Retraction Watch.

Amid controversial Sarepta approval decision, FDA head calls for key study retraction

The head of the U.S. Food and Drug Administration (FDA) has called for the retraction of a study about a drug that the agency itself approved earlier this week, despite senior staff opposing the approval. On September 19, the FDA okayed eteplirsen to treat Duchenne muscular dystrophy (DMD), a rare genetic disorder that results in muscle degeneration and […]

The post Amid controversial Sarepta approval decision, FDA head calls for key study retraction appeared first on Retraction Watch.

Neuro journal pulls article for data theft, prompts misconduct probe

Neuroscientists have retracted a research letter less than two months after it appeared, admitting they appeared to pass off others’ data as their own. Two of the researchers are listed as affiliated with the University of California, San Francisco (UCSF), and the incident has led to a misconduct investigation at the institution, a UCSF spokesperson told […]

The post Neuro journal pulls article for data theft, prompts misconduct probe appeared first on Retraction Watch.